Takeda ties up with startup on cancer immunotherapy
September 4, 2017
TOKYO- Takeda Pharmaceutical Co. said Monday it has entered into a collaboration with Tokyo-based startup Noile-Immune Biotech Inc. on research and development for cancer immunotherapy.
Noile-Immune Biotech was launched in 2015 by the National Cancer Center Japan and Yamaguchi University.
The tie-up will include a next-generation therapy involving chimeric antigen receptor T cells, or CAR-T cells, which contain genes of antibodies that could recognize cancer and genes that stimulate activity in cells that attack tumor cells. Jiji Press
Latest Videos
- GEORGE SOROS BLASTED THE U S FOR SUPPORTING ISRAEL ON NOT WORKING WITH HAMAS
- WIKILEAKS REVELATIONS SHOW U S ‘IGNORED’ TORTURE FROM THE WAR IN IRAQ
- THE ROOTS OF THE ISRAEL PALESTINE CONFLICT
- TUCKER CARLSON QUESTIONS U.S SUPPORT FOR ISRAEL WAR
- RFK Jr TO RUN FOR PRESIDENT AS INDEPENDENT, DECLARING INDEPENDENCE FROM THE TWO POLITICAL PARTIES
- JAPANESE VIROLOGIST SAYS OMICRON MAY HAVE BEEN MANUFACTURED
- JAPANESE VIEW & FILIPINO BEAUTY
